Frontiers in Cell and Developmental Biology · 2020 · 57 citations · 21 references
PharmacyBioengineeringCell BiologyCell TherapyRegenerative MedicineStem Cell BiologyCell CharacterizationCell CultureCell ManufacturingCell Therapy ManufacturingMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyBone Marrow-derived Mesenchymal Stromal CellsCell Viability AssaysInter-laboratory ComparisonLineage DifferentiationMesenchymal Stromal Cell CharacterizationMesenchymal Stromal Cell CultureMesenchymal Stromal Cell ManufacturingMesenchymal Stromal Cell Phenotyping
BACKGROUND: Culture-derived mesenchymal stromal cells (MSCs) exhibit variable characteristics when manufactured using different methods and different source materials. The purpose of this study was to assess the impact on MSC characteristics when different laboratories propagated MSCs from cultures initiated with BM aliquots derived from the same donor source material. METHODS AND METHODS: . Post-thawed MSCs from each laboratory were analyzed for cell viability, immunophenotype, tri-lineage differentiation, fibroblast colony-forming units (CFU-F), gene expression, and immunosuppressive activity. RESULTS: Transit times from BM collection to receipt by laboratories located in the United States ranged from 16.0-30.0 h and from 41.5-71.5 h for a laboratory in Asia. Post-thaw culture derived MSCs rom BM #1, #2, and #3 exhibited viabilities that ranged from 74-92%, 61-96%, and 23-90%, respectively. CFU activity from BM #1, #2, and #3 per 200 MSCs plated averaged 45.1 ± 21.4, 49.3 ± 26.8 and 14.9 ± 13.3, respectively. No substantial differences were observed in immunophenotype, and immunosuppressive activities. Global gene expression profiles of MSCs revealed transcriptome differences due to different inter-laboratory methods and to donor source material with the center effects showing greater molecular differences than source material. CONCLUSION: Functional and molecular differences exist among MSCs produced by different centers even when the same BM starting material is used to initiate cultures. These results indicated that manufacturing of MSCs by five independent centers contributed more to MSC variability than did the source material of the BM used in this study. Thus, emphasizing the importance of establishing worldwide standards to propagate MSCs for clinical use.
21